CD274 and gastric cancer: While early study suggested some evidence for the potential interchangeability between the 22C3 pharmDx and 28-8 pharmDx assays in gastric cancer [20], subsequent reports highlighted suboptimal concordance rates of PD-L1 CPS by 28-8 and 22C3 assay [21].